Association of Molecular Marker Status With Graded Prognostic Assessment of Lung Cancer With Brain Metastases

被引:1
|
作者
Suh, John H. [1 ,2 ,3 ]
机构
[1] Cleveland Clin, Dept Radiat Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA
[2] Cleveland Clin, Rose Ella Burkhardt Brain Tumor & Neurooncol Ctr, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
关键词
SURVIVAL;
D O I
10.1001/jamaoncol.2016.3818
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:831 / 832
页数:3
相关论文
共 50 条
  • [21] External Validation of the Graded Prognostic Assessment for Patients with Non-Small Cell Lung Cancer and Brain Metastases Using Molecular Markers (Lung-molGPA)
    Hong, S. W.
    Jeon, W.
    Kim, J. S., Jr.
    Song, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E24 - E25
  • [22] Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
    Li, Ji
    Jing, Wang
    Zhai, Xiaoyang
    Jia, Wenxiao
    Zhu, Hui
    Yu, Jinming
    ONCOTARGETS AND THERAPY, 2021, 14 : 1623 - 1631
  • [23] Physician Assessment Versus the Graded Prognostic Assessment (GPA) for Brain Metastases
    Aggarwal, S.
    Prionas, N. D.
    Carter, J. N.
    Pradhan, P.
    Bui, J. L.
    Fujimoto, D. K.
    von Eyben, R.
    Koong, A. C.
    Chang, D. T.
    Ho, C. K.
    Soltys, S. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E126 - E126
  • [24] New graded prognostic assessment (GPA) in breast cancer brain metastases in a contemporary cohort
    Ahluwalia, Manmeet S.
    Chi, Ming
    Venur, Vyshak Alva
    Budd, Thomas
    Angelov, Lilyana
    Chao, Samuel
    Elson, Paul
    Barnett, Gene H.
    Abraham, Jame
    CANCER RESEARCH, 2015, 75
  • [25] Selecting Optimal Timing of Cranial Radiotherapy Based on the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA) in Patients with NonSmall Cell Lung Cancer and Brain Metastases
    Zhai, X.
    Li, J.
    Jing, W.
    Jia, W.
    Zhu, H.
    Yu, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E66 - E66
  • [26] Validation of a modified lung graded prognostic assessment as a tool for survival in NSCLC patients with brain metastases
    Xie, M.
    Zhang, J.
    Li, X.
    You, Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [27] Applicability of the adjusted graded prognostic assessment for lung cancer with brain metastases using molecular markers (Lung-molGPA) in a Chinese cohort: A retrospective study of multiple institutions
    Zhang, Tingyou
    Zhang, Yu
    Zhou, Lin
    Deng, Shanshan
    Huang, Meijuan
    Liu, Yuncong
    Liu, Yongmei
    Gong, Youlin
    Zhu, Jiang
    Xue, Jianxin
    Bai, Yuju
    Ma, Hu
    Zhang, Yan
    Yu, Min
    Li, Yanying
    Wang, Yongsheng
    Zou, Bingwen
    Zhou, Xiaojuan
    Xiu, Weigang
    Na, Feifei
    Xu, Yong
    Peng, Feng
    Wang, Jin
    Lu, You
    CANCER MEDICINE, 2020, 9 (23): : 8772 - 8781
  • [28] Graded prognostic assessment index for melanoma with brain metastases (MBM)
    Osei-Boateng, Kwabena
    Venur, Vyshak Alva
    Dahiya, Saurabh
    Du, Lingling
    Garje, Rohan
    Elson, Paul
    Chao, Samuel T.
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Validation of the graded prognostic assessment index for patients with brain metastases
    Nieder, Carsten
    Marienhagen, Kirsten
    Geinitz, Hans
    Molls, Michael
    ACTA ONCOLOGICA, 2009, 48 (03) : 457 - 459
  • [30] Surgical resection of brain metastases: the prognostic value of the graded prognostic assessment score
    A. S. Jakola
    S. Gulati
    U. S. Nerland
    O. Solheim
    Journal of Neuro-Oncology, 2011, 105 : 573 - 581